Rita Alloro
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Rita Alloro has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Dario Raimondo
Gastroenterology & Endoscopy Unit, Fondazione Istituto-G. Giglio, Contrada Pietra Pollastra Pisciotto, 90015 Cefalù, Italy
5 shared publications - Emanuele Sinagra
Gastroenterology and Endoscopy Unit, Fondazione Istituto San Raffaele Giglio, 90015 Cefalù, Italy
5 shared publications - Francesca Rossi
Gastroenterology & Endoscopy Unit, Fondazione Istituto-G. Giglio, Contrada Pietra Pollastra Pisciotto, 90015 Cefalù, Italy
5 shared publications - Giuseppe Conoscenti
Gastroenterology & Endoscopy Unit, Fondazione Istituto-G. Giglio, Contrada Pietra Pollastra Pisciotto, 90015 Cefalù, Italy
5 shared publications - Marcello Maida
Kore University of Enna, Italy
4 shared publications - Socrate Pallio
Department of Clinical and Experimental Medicine, University of Messina, 98100 Messina, Italy
3 shared publications
Latest Publications
- Open Access
- 8 August 2026
- Published by MDPI AG in Gastroenterology Insights
- Vol. 17 (3) , 43
Perceived Knowledge of the Use of Probiotics in Irritable Bowel Syndrome: A Cross-Sectional Survey
Background and Objectives: This study aimed to characterize physicians’ knowledge and practice patterns regarding the use of probiotics in the management of irritable bowel syndrome (IBS). By examining clinical experiences and barriers to adoption, this research sought to identify critical gaps in practice and establish a foundation for evidence-based improvements in patient care. Materials and Methods: The survey was conducted in accordance with the CROSS (Consensus-based Checklist for Reporting of Survey Studies) guidelines. Attendees of a medical congress, specifically general practitioners, gastroenterologists, surgeons, and internists with an interest in the clinical significance and therapeutic modulation of the human microbiome, were invited to participate. Participants completed a 38-item, paper-based questionnaire. The instrument assessed respondents’ self-perceived knowledge of probiotics, their understanding of probiotic definitions and specific strains, and their current clinical practice patterns—particularly regarding the management of irritable bowel syndrome (IBS). Additionally, the survey explored information sources, the frequency of self-prescription, and the perceived need for further education, with a specific focus on safety profiles and clinical concerns. Results: Of the 70 invited attendees, 68 completed the survey, yielding a response rate of 97.1%. The respondent cohort included 40 general practitioners (GPs), 20 gastroenterologists (GEs), four surgeons (SSs), and four internists (SIMs). More than half of the respondents were female (n = 37, 54.4%), with a median age of 43 years (range: 28–70). Exactly half of the respondents (n = 34, 50.0%) agreed that probiotics always have a role in the management of irritable bowel syndrome (IBS); however, only 44.1% (n = 30) reported familiarity with the relevant scientific literature on probiotics. Furthermore, respondents more frequently recognized bacterial species associated with single-strain probiotic formulations compared to those in multi-strain mixtures. The primary concern regarding the administration of probiotics for IBS was this lack of familiarity with the scientific literature, cited by 23.5% of respondents. Notably, 100% of the surveyed cohort expressed a need for further education on the topic. Conclusions: The emergence of scientific and clinical evidence results in a clinical practice characterized by high prescribing habits, despite the lack of formal approval. These findings highlight evidence showing the effectiveness of certain probiotic strains in managing IBS symptoms, suggesting the need for standardized guidelines. Given the demonstrated need for further education among the surveyed cohort, integrating probiotic-specific training into both undergraduate medical curricula and continuing professional development programs could significantly enhance the clinical knowledge and awareness of both current and future practitioners.
- 8 August 2026
- Published by MDPI AG in Gastroenterology Insights
- Vol. 17 (3) , 43
Open AccessPerceived Knowledge of the Use of Probiotics in Irritable Bowel Syndrome: A Cross-Sectional Survey
Background and Objectives: This study aimed to characterize physicians’ knowledge and practice patterns regarding the use of probiotics in the management of irritable bowel syndrome (IBS). By examining clinical experiences and barriers to adoption, this research sought to identify critical gaps in practice and establish a foundation for evidence-based improvements in patient care. Materials and Methods: The survey was conducted in accordance with the CROSS (Consensus-based Checklist for Reporting of Survey Studies) guidelines. Attendees of a medical congress, specifically general practitioners, gastroenterologists, surgeons, and internists with an interest in the clinical significance and therapeutic modulation of the human microbiome, were invited to participate. Participants completed a 38-item, paper-based questionnaire. The instrument assessed respondents’ self-perceived knowledge of probiotics, their understanding of probiotic definitions and specific strains, and their current clinical practice patterns—particularly regarding the management of irritable bowel syndrome (IBS). Additionally, the survey explored information sources, the frequency of self-prescription, and the perceived need for further education, with a specific focus on safety profiles and clinical concerns. Results: Of the 70 invited attendees, 68 completed the survey, yielding a response rate of 97.1%. The respondent cohort included 40 general practitioners (GPs), 20 gastroenterologists (GEs), four surgeons (SSs), and four internists (SIMs). More than half of the respondents were female (n = 37, 54.4%), with a median age of 43 years (range: 28–70). Exactly half of the respondents (n = 34, 50.0%) agreed that probiotics always have a role in the management of irritable bowel syndrome (IBS); however, only 44.1% (n = 30) reported familiarity with the relevant scientific literature on probiotics. Furthermore, respondents more frequently recognized bacterial species associated with single-strain probiotic formulations compared to those in multi-strain mixtures. The primary concern regarding the administration of probiotics for IBS was this lack of familiarity with the scientific literature, cited by 23.5% of respondents. Notably, 100% of the surveyed cohort expressed a need for further education on the topic. Conclusions: The emergence of scientific and clinical evidence results in a clinical practice characterized by high prescribing habits, despite the lack of formal approval. These findings highlight evidence showing the effectiveness of certain probiotic strains in managing IBS symptoms, suggesting the need for standardized guidelines. Given the demonstrated need for further education among the surveyed cohort, integrating probiotic-specific training into both undergraduate medical curricula and continuing professional development programs could significantly enhance the clinical knowledge and awareness of both current and future practitioners.
- Open Access
- 23 July 2026
- Published by IntechOpen
The Approach to Colorectal Lesions: Between Operator Experience and Artificial Intelligence
While colonoscopy remains the gold standard for colorectal neoplasia screening and therapeutic resection, its clinical efficacy is often compromised by significant interoperator variability in adenoma detection rates (ADR) and characterization precision. To address these disparities, Artificial intelligence (AI) systems – specifically deep learning-based computer-aided detection (CADe) and computer-aided diagnosis (CADx) – have been integrated into clinical practice to augment endoscopic performance through enhanced lesion recognition and real-time optical biopsy. This review synthesizes evidence from randomized controlled trials, meta-analyses, and clinical guidelines up to 2025 to evaluate the interplay between endoscopist expertise and AI assistance. Current data indicate that AI-augmented colonoscopy significantly optimizes ADR and the detection of diminutive or nonpolypoid lesions. Furthermore, CADx frameworks demonstrate robust accuracy in predicting real-time histology, potentially facilitating “resect-and-discard” strategies. However, widespread implementation is currently hindered by algorithmic biases, variable external validity, false-positive rates, and unresolved medicolegal implications. Ultimately, AI serves as a potent diagnostic adjunct that reduces operator dependency. Optimal clinical outcomes depend on a synergistic integration of seasoned endoscopic judgment and validated AI algorithms, supported by standardized training and transparent regulatory frameworks.
- 23 July 2026
- Published by IntechOpen
Open AccessThe Approach to Colorectal Lesions: Between Operator Experience and Artificial Intelligence
While colonoscopy remains the gold standard for colorectal neoplasia screening and therapeutic resection, its clinical efficacy is often compromised by significant interoperator variability in adenoma detection rates (ADR) and characterization precision. To address these disparities, Artificial intelligence (AI) systems – specifically deep learning-based computer-aided detection (CADe) and computer-aided diagnosis (CADx) – have been integrated into clinical practice to augment endoscopic performance through enhanced lesion recognition and real-time optical biopsy. This review synthesizes evidence from randomized controlled trials, meta-analyses, and clinical guidelines up to 2025 to evaluate the interplay between endoscopist expertise and AI assistance. Current data indicate that AI-augmented colonoscopy significantly optimizes ADR and the detection of diminutive or nonpolypoid lesions. Furthermore, CADx frameworks demonstrate robust accuracy in predicting real-time histology, potentially facilitating “resect-and-discard” strategies. However, widespread implementation is currently hindered by algorithmic biases, variable external validity, false-positive rates, and unresolved medicolegal implications. Ultimately, AI serves as a potent diagnostic adjunct that reduces operator dependency. Optimal clinical outcomes depend on a synergistic integration of seasoned endoscopic judgment and validated AI algorithms, supported by standardized training and transparent regulatory frameworks.
- Open Access
- 4 April 2023
- Published by MDPI AG in Gastroenterology Insights
- Vol. 14 (2) , 178-190
Gastric Syphilis Presenting as a Nodal Inflammatory Pseudotumor Mimicking a Neoplasm: Don’t Forget the Treponema! Case Report and Scoping Review of the Literature of the Last 65 Years
Despite the fact that gastric syphilis is considered rare, it is reported as a type of organic involvement that is present in a large proportion of secondary syphilis cases, even though gastritis presenting with symptoms is extremely rare. Clinical, radiological, and endoscopic findings are non-specific and frequently mimic the symptoms of gastric adenocarcinoma or lymphoma, making diagnosis difficult. Immunostaining is required for this diagnosis. We would like to emphasize the importance of being suspicious of GS when a gastric mass exhibits the histologic features of an inflammatory pseudotumor (IPT), as previously reported for nodal IPT caused by luetic infection. We described a 56-year-old man who presented to the oncology department with a 3-month history of anorexia, epigastric pain, nausea, vomiting, and weight loss, as well as an initial radiological and endoscopic suspicion of gastric adenocarcinoma, in which immune staining allowed us to diagnose GS. In addition, we conducted an updated scoping review of the scientific literature to show the clinical, laboratory, and therapeutic findings in GS patients over the last 65 years.
- 4 April 2023
- Published by MDPI AG in Gastroenterology Insights
- Vol. 14 (2) , 178-190
Open AccessGastric Syphilis Presenting as a Nodal Inflammatory Pseudotumor Mimicking a Neoplasm: Don’t Forget the Treponema! Case Report and Scoping Review of the Literature of the Last 65 Years
Despite the fact that gastric syphilis is considered rare, it is reported as a type of organic involvement that is present in a large proportion of secondary syphilis cases, even though gastritis presenting with symptoms is extremely rare. Clinical, radiological, and endoscopic findings are non-specific and frequently mimic the symptoms of gastric adenocarcinoma or lymphoma, making diagnosis difficult. Immunostaining is required for this diagnosis. We would like to emphasize the importance of being suspicious of GS when a gastric mass exhibits the histologic features of an inflammatory pseudotumor (IPT), as previously reported for nodal IPT caused by luetic infection. We described a 56-year-old man who presented to the oncology department with a 3-month history of anorexia, epigastric pain, nausea, vomiting, and weight loss, as well as an initial radiological and endoscopic suspicion of gastric adenocarcinoma, in which immune staining allowed us to diagnose GS. In addition, we conducted an updated scoping review of the scientific literature to show the clinical, laboratory, and therapeutic findings in GS patients over the last 65 years.
- Open Access
Microbiota Gut–Brain Axis in Ischemic Stroke: A Narrative Review with a Focus about the Relationship with Inflammatory Bowel Disease
The gut microbiota is emerging as an important player in neurodevelopment and aging as well as in brain diseases including stroke, Alzheimer’s disease, and Parkinson’s disease. The complex interplay between gut microbiota and the brain, and vice versa, has recently become not only the focus of neuroscience, but also the starting point for research regarding many diseases such as inflammatory bowel diseases (IBD). The bi-directional interaction between gut microbiota and the brain is not completely understood. The aim of this review is to sum up the evidencesconcerningthe role of the gut–brain microbiota axis in ischemic stroke and to highlight the more recent evidences about the potential role of the gut–brain microbiota axis in the interaction between inflammatory bowel disease and ischemic stroke.
Open AccessMicrobiota Gut–Brain Axis in Ischemic Stroke: A Narrative Review with a Focus about the Relationship with Inflammatory Bowel Disease
The gut microbiota is emerging as an important player in neurodevelopment and aging as well as in brain diseases including stroke, Alzheimer’s disease, and Parkinson’s disease. The complex interplay between gut microbiota and the brain, and vice versa, has recently become not only the focus of neuroscience, but also the starting point for research regarding many diseases such as inflammatory bowel diseases (IBD). The bi-directional interaction between gut microbiota and the brain is not completely understood. The aim of this review is to sum up the evidencesconcerningthe role of the gut–brain microbiota axis in ischemic stroke and to highlight the more recent evidences about the potential role of the gut–brain microbiota axis in the interaction between inflammatory bowel disease and ischemic stroke.
- Open Access
- 13 January 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (2) , 268
Could Chronic Idiopatic Intestinal Pseudo-Obstruction Be Related to Viral Infections?
Chronic idiopathic intestinal pseudo-obstruction (CIIPO) is a disease characterized by symptoms and signs of small bowel obstruction in the absence of displayable mechanical obstruction. Due to the known neuropathic capacity of several viruses, and their localization in the intestine, it has been hypothesized that such viruses could be involved in the pathogenesis of CIIPO. The most frequently involved viruses are John Cunningham virus, Herpesviridae, Flaviviruses, Epstein–Barr virus and Citomegalovirus. Therefore, the present narrative review aims to sum up some new perspectives in the etiology and pathophysiology of CIIPO.
- 13 January 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (2) , 268
Open AccessCould Chronic Idiopatic Intestinal Pseudo-Obstruction Be Related to Viral Infections?
Chronic idiopathic intestinal pseudo-obstruction (CIIPO) is a disease characterized by symptoms and signs of small bowel obstruction in the absence of displayable mechanical obstruction. Due to the known neuropathic capacity of several viruses, and their localization in the intestine, it has been hypothesized that such viruses could be involved in the pathogenesis of CIIPO. The most frequently involved viruses are John Cunningham virus, Herpesviridae, Flaviviruses, Epstein–Barr virus and Citomegalovirus. Therefore, the present narrative review aims to sum up some new perspectives in the etiology and pathophysiology of CIIPO.